Phase 1 Clinical Study for Evaluating the Safety and Efficacy of a Transdermal Injection of JX-594 (Thymidine Kinase (-)/GM-CSF(+) Vaccinia Virus) Within the Tumor of Patients With Hepatic Carcinoma
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Pexastimogene devacirepvec (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- Sponsors Jennerex
- 02 Jan 2018 According to a GC Pharma media release, Green Cross Corporation rebrands itself to GC Pharma.
- 15 Jul 2008 Results for three patients with liver cancer published in Molecular Therapy in July 2008
- 27 Feb 2008 Results have been reported at the AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference.